Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Symptoms observed in acute lung injury include severe shortness of breath, low blood pressure, confusion, and extreme tiredness. This type of injury has a substantial impact on public health, with a high incidence across the world and it requires administration of a fast and goal-oriented therapy to suppress further lung damage.
The major factor that drives the acute lung injury market is rise in prevalence of lung-related diseases, increase in geriatric population, growth in awareness about daily health diagnostics, and technological advancements. However, high cost of therapies, and low adoption rate of digital radiography and portable spirometers for diagnosing the condition impede the market growth. Furthermore, advancements in surgical techniques and the perioperative management, and development of new treatment strategies to improve outcomes are expected to provide numerous opportunities for market expansion in the near future.
The global acute lung injury market is segmented based on therapy, end user, and region. Based on therapy, it is categorized into pharmacotherapy, mechanical ventilation, adjunctive procedures, fluid management, and others. Based on end user, it is segmented into hospitals, clinics, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include Altor BioScience Corporation, FirstString Research, Inc., GlaxoSmithKline Plc, Forschung und Entwicklung GmbH, Commence Bio, Inc., CompleGen, Inc., Histocell S.L., Stemedica Cell Technologies, Inc., Windtree Therapeutics, Inc., and S-Evans Biosciences, Inc.
- The study provides an in-depth analysis of the global acute lung injury market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Acute Lung Injury Market Key Segments:
- Mechanical Ventilation
- Adjunctive Procedures
- Fluid Management
By End User
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
Future Industry Insight Inc. focuses on custom research, management consulting, IPO consulting, industry chain research, and data base &seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 15 years experiences on marketing.
Company Name: Future Industry Insight Inc.
Designation: Global Sales Manager
City: New York
Country: United States